Bausch Health Companies

BHCNYSE Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.173 B

$5.81 +3.01%

Close of 22 Sept 2026

Revenue

$10.3B

#411 by revenue

Earnings

$157.0M

#1108 by earnings

Shares outstanding

373,990,561

Latest filing cover page

P/E ratio

13.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#100Aurinia PharmaceuticalsAUPH$2.22B
#101Sarepta TherapeuticsSRPT$2.20B
#102Bausch Health CompaniesBHC$2.17B
#103Trevi TherapeuticsTRVI$2.17B
#104Zenas BioPharmaZBIO$2.15B

What if Bausch Health Companies were worth as much as…

Open the what-if tool →

Gold $30.2T

$80,841.53

Per share 13,914× higher

Bitcoin $1.74T

$4,656.95

Per share 802× higher

Nvidia $5.52T

$14,748.41

Per share 2,538× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Bausch Health Companies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.